Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:42 pm Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
Laurence W. Lytton | 1,153,488 6.800% |
282,307 (+32.41%) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Stryve Foods, Inc. SNAX |
Laurence W. Lytton | 194,780 8.900% |
194,780 (New Position) |
Filing History |
| 2024-02-14 2:27 pm Purchase |
2023-12-31 | 13G | Societal CDMO, Inc. SCTL |
Laurence W. Lytton | 10,340,858 9.900% |
3,847,168 (+59.24%) |
Filing History |
| 2024-02-14 2:22 pm Purchase |
2023-12-31 | 13G | Rail Vision Ltd. RVSN |
Laurence W. Lytton | 450,000 9.300% |
252,500 (+127.85%) |
Filing History |
| 2024-02-14 2:09 pm Purchase |
2023-12-31 | 13G | RingCentral, Inc. RNG |
Laurence W. Lytton | 1,528,157 1.800% |
1,528,157 (New Position) |
Filing History |
| 2024-02-14 2:03 pm Purchase |
2023-12-31 | 13G | Molecular Templates, Inc. MTEM |
Laurence W. Lytton | 232,951 4.300% |
232,951 (New Position) |
Filing History |
| 2024-02-14 1:59 pm Sale |
2023-12-31 | 13G | Miromatrix Medical Inc. MIRO |
Laurence W. Lytton | 0 0.000% |
-1,380,367 (Position Closed) |
Filing History |
| 2024-02-14 1:49 pm Purchase |
2023-12-31 | 13G | LiqTech International, Inc. LIQT |
Laurence W. Lytton | 589,653 9.990% |
589,653 (New Position) |
Filing History |
| 2024-02-14 1:43 pm Sale |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Laurence W. Lytton | 585,013 1.000% |
-3,855,175 (-86.82%) |
Filing History |
| 2024-02-14 1:36 pm Purchase |
2023-12-31 | 13G | Giga-tronics Incorporated GIGA |
Laurence W. Lytton | 608,177 9.990% |
4,477 (+0.74%) |
Filing History |
| 2024-02-14 1:31 pm Purchase |
2023-12-31 | 13G | EMCORE Corporation EMKR |
Laurence W. Lytton | 778,733 9.990% |
486,406 (+166.39%) |
Filing History |
| 2024-02-14 1:23 pm Sale |
2023-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
Laurence W. Lytton | 482,976 6.700% |
-151,049 (-23.82%) |
Filing History |
| 2024-02-14 1:18 pm Unchanged |
2023-12-31 | 13G | Gyre Therapeutics, Inc. GYRE |
Laurence W. Lytton | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 1:10 pm Purchase |
2023-12-31 | 13G | BIOLASE INC PAR $.001 BIOLQ |
Laurence W. Lytton | 26,824 0.600% |
26,824 (New Position) |
Filing History |
| 2024-02-14 1:05 pm Sale |
2023-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Laurence W. Lytton | 2,185,364 4.200% |
-799,439 (-26.78%) |
Filing History |
| 2024-01-11 1:04 pm Purchase |
2023-12-28 | 13G | NeuroOne Medical Technologies Corporation NMTC |
Laurence W. Lytton | 1,304,102 5.200% |
1,304,102 (New Position) |
Filing History |
| 2023-12-07 5:15 pm Purchase |
2023-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Laurence W. Lytton | 1,885,073 9.990% |
1,885,073 (New Position) |
Filing History |
| 2023-08-31 11:59 am Purchase |
2023-08-24 | 13G | Societal CDMO, Inc. SCTL |
Laurence W. Lytton | 6,493,690 5.800% |
5,514,741 (+563.33%) |
Filing History |
| 2023-08-14 12:20 pm Purchase |
2023-08-02 | 13G | Alimera Sciences, Inc. ALIM |
Laurence W. Lytton | 2,984,803 5.700% |
2,984,803 (New Position) |
Filing History |
| 2023-07-20 5:09 pm Purchase |
2023-07-13 | 13G | Molecular Templates, Inc. MTEM |
Laurence W. Lytton | 276,157 5.100% |
276,157 (New Position) |
Filing History |